Scholarlink

Background <p>This study evaluated the effects of difelikefalin, a kappa opioid receptor (KOR) agonist, on the inflammatory response and renal dysfunction in a rat model of acute kidney injury induced by renal ischemia–reperfusion injury, comparing it with other KOR agonists.</p> Methods <p>One week after right nephrectomy, rats received one of three drugs (difelikefalin, nalfurafine hydrochloride, or U-50488H). Thirty minutes later, ischemia was induced in the left kidney by clamping its artery and vein for 45&#xa0;min. Rats were then transferred to metabolic cages for 24-h urine collection, and blood was taken at the 24-h time point. Renal function (blood urea nitrogen [BUN], serum creatinine [SCr], and creatinine clearance [CCr]) and 23 serum cytokines were assessed, along with histopathological evaluation of renal tubular damage.</p> Results <p>Compared with the sham group, the vehicle group showed increased BUN and SCr levels, reduced CCr, and renal tubular damage. Difelikefalin improved BUN, SCr, and CCr levels and mitigated renal tubular damage. Similar effects were observed with nalfurafine hydrochloride and U-50488H. Thirteen serum cytokines were elevated in the vehicle group. Difelikefalin suppressed all elevated cytokines, U-50488H showed moderate efficacy, and nalfurafine hydrochloride exhibited little inhibitory effect.</p> Conclusion <p>These findings indicate that difelikefalin has anti-inflammatory and renoprotective effects in a rat acute kidney injury model, with varying anti-inflammatory efficacy among KOR agonists.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anti-inflammatory and renoprotective effects of difelikefalin, a kappa opioid receptor agonist, in a rat model of renal ischemia–reperfusion-induced acute kidney injury

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Hiroto Takeuchi,
  • Satoshi Tatemichi,
  • Yuji Okuhara

摘要

Background

This study evaluated the effects of difelikefalin, a kappa opioid receptor (KOR) agonist, on the inflammatory response and renal dysfunction in a rat model of acute kidney injury induced by renal ischemia–reperfusion injury, comparing it with other KOR agonists.

Methods

One week after right nephrectomy, rats received one of three drugs (difelikefalin, nalfurafine hydrochloride, or U-50488H). Thirty minutes later, ischemia was induced in the left kidney by clamping its artery and vein for 45 min. Rats were then transferred to metabolic cages for 24-h urine collection, and blood was taken at the 24-h time point. Renal function (blood urea nitrogen [BUN], serum creatinine [SCr], and creatinine clearance [CCr]) and 23 serum cytokines were assessed, along with histopathological evaluation of renal tubular damage.

Results

Compared with the sham group, the vehicle group showed increased BUN and SCr levels, reduced CCr, and renal tubular damage. Difelikefalin improved BUN, SCr, and CCr levels and mitigated renal tubular damage. Similar effects were observed with nalfurafine hydrochloride and U-50488H. Thirteen serum cytokines were elevated in the vehicle group. Difelikefalin suppressed all elevated cytokines, U-50488H showed moderate efficacy, and nalfurafine hydrochloride exhibited little inhibitory effect.

Conclusion

These findings indicate that difelikefalin has anti-inflammatory and renoprotective effects in a rat acute kidney injury model, with varying anti-inflammatory efficacy among KOR agonists.